Showing results (191-200 of 443) with videos related to
Sort By:
Pageof 45
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2014
Removing T-cell epitopes with computational protein designChris King, Esteban N Garza, Ronit Mazor, et al.Blood|November 8, 2008
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityJohn E Weldon, Laiman Xiang, Oleg Chertov, et al.British Journal of Haematology|June 10, 2010
Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemiaFrancis Mussai, Dario Campana, Deepa Bhojwani, et al.Leukemia & Lymphoma|May 24, 2011
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemiaRobert J Kreitman, Evgeny Arons, Maryalice Stetler-Stevenson, et al.Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategyHui Wei, Laiman Xiang, Alan S Wayne, et al.Lung Cancer (Amsterdam, Netherlands)|September 12, 2009
Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapyRaffit Hassan, Charles Schweizer, Kun F Lu, et al.Plos One|June 6, 2012
ANKRD26 and its interacting partners TRIO, GPS2, HMMR and DIPA regulate adipogenesis in 3T3-L1 cellsXiu-Fen Liu, Tapan K Bera, Charissa Kahue, et al.European Journal of Immunology|May 1, 2008
Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodiesMalka Epel, Irit Carmi, Sharon Soueid-Baumgarten, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignanciesRalph F Alderson, Robert J Kreitman, Tianling Chen, et al.Frontiers in Oncology|August 21, 2019
The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver CancerAarti Kolluri, Mitchell HoPageof 45